Story
China Reviews Broadcom's Dominance in State-Owned Data Centers, FT Reports
Summary
Chinese authorities are reportedly examining the prevalence of Broadcom's data center switches in state-owned enterprises, a move that could curb reliance on the U.S. chipmaker amid a push for technological self-sufficiency.
Chinese authorities are examining the use of Broadcom Inc.'s (NASDAQ:AVGO) networking switches within state-backed data centers, signaling a potential move to reduce reliance on foreign technology, the Financial Times reported on Wednesday.
Details of the Review
According to the report, which cited people familiar with the matter, China's State-owned Assets Supervision and Administration Commission (SASAC) has recently surveyed the number of Broadcom switches deployed in data centers controlled by state-owned enterprises.
The survey uncovered a significant dependence on the U.S. chipmaker's hardware. In some state-controlled companies, Broadcom's switches were found to account for as much as 90% of the equipment, one person told the FT. These findings could lead to informal government guidance for these enterprises to decrease their use of Broadcom products.
AdMarket Context and Implications
This review is a component of Beijing's broader strategic push for “domestic chips for domestic use,” aimed at strengthening local technology suppliers and enhancing national security. The move could directly benefit Chinese competitors such as Huawei, H3C Technologies, and Ruijie Networks (SZ:301165).
In the high-end data-center switch market in China, Broadcom competes with Nvidia (NASDAQ:NVDA) and Huawei. However, state-backed facilities have already been restricted from using certain Nvidia products due to U.S. export controls, a situation that has created opportunities for domestic firms. A similar reduction in Broadcom's footprint would further accelerate this trend toward supply chain localization in China's critical digital infrastructure.
Read next
More on Stocks
Natera Stock Hits 52-Week High on Japanese Approval for Cancer Test
Shares of molecular diagnostics firm Natera Inc. surged to a new 52-week high after securing regulatory approval in Japan for its Signatera test as a companion diagnostic for a specific type of bladder cancer.
Novo Nordisk Considers Upgrading to Direct NYSE Listing, CEO Tells FT
Novo Nordisk's CEO has indicated the Danish pharmaceutical giant is open to replacing its American depositary receipts with a direct listing on the New York Stock Exchange to raise its profile in the U.S.
AIC Mines to Acquire Mt Cuthbert Copper Project for $120M, Shares Jump 14.5%
Australian copper producer AIC Mines has agreed to a $120 million deal to acquire the Mt Cuthbert copper project, a move that boosts its total resources by 39% and sent its share price up sharply.
Qualcomm Stock Surges Nearly 20% on Google AI Laptop Deal, Data Center Progress
Qualcomm shares have climbed almost 20% this month following the announcement of a partnership with Google for AI-powered laptops and a successful demonstration of its AI data center interconnect technology.